Buprenorphine transdermal skin patch and Dihydroergotamine nasal
Determining the interaction of Buprenorphine transdermal skin patch and Dihydroergotamine nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Dihydroergotamine Nasal Spray
- Buprenorphine transdermal skin patch-Dilacor XR
- Buprenorphine transdermal skin patch-Dilantin
- Buprenorphine transdermal skin patch-Dilantin Infatabs
- Buprenorphine transdermal skin patch-Dilantin injection
- Buprenorphine transdermal skin patch-Dilantin Kapseals
- Dihydroergotamine nasal-Buprenorphine, Buprenorphine Hydrochloride
- Dihydroergotamine nasal-Buprenorphine/naloxone Oromucosal, Sublingual
- Dihydroergotamine nasal-Buproban
- Dihydroergotamine nasal-Bupropion
- Dihydroergotamine nasal-Bupropion and naltrexone
- Dihydroergotamine nasal-Bupropion Extended-Release Tablets